UCSF - Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, 94143, United States
Location contact
Katherine Steineman
CONTACT
Lucas Zier, MD, MS
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07822581
The purpose of this research is to collect the magnetic signals from the heart to identify features that may help Emergency Department (ED) doctors differentiate high and low risk patients for heart related chest pain.
Trial opening soon.
Get Notified22 year and older
All sexes
Observational
San Francisco, California, 94143, United States
Katherine Steineman
CONTACT
Lucas Zier, MD, MS
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The SandboxAQ CardiAQ System is an investigational device, and it is intended to non-invasively measure and display the magnetic signals produced by the electric currents in the heart. Its purpose is to assist in the evaluation of myocardial ischemia and infarction risks, in patients with symptoms suggestive of ACS. It is intended to complement clinical judgment and to augment standard of care diagnostic tools.
Time frame: Up to 30 Days
The main objective of the study is to collect MCG and other clinical data from the intended patient population for training machine learning algorithms to identify the presence of High Risk - Coronary Artery Disease (HRCAD).
Time frame: Day 1
The second objective is to characterize changes in MCG, if any, over the course of a patient's evaluation workflow in the ED, with a repeat MCG scan.
Contact information is provided by the study sponsor or research team.
SB Technology, Inc.
Industry
"Discovery2" Study of Using Magnetocardiography (MCG) at Emergency Departments
Acronym: Discovery2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07192965
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Jette, Belgium
View Trial DetailsNCT06853626
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Lyngseidet, Lyngen, Norway
View Trial DetailsNCT07479056
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Seoul, Eunpyeong-gu, South Korea
View Trial DetailsNCT07641257
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
View Trial Details